Infliximab treatment in two patients with psoriatic arthritis and secondary IgA nephropathy.
Sakellariou
Grigorios T
GT
Department of Rheumatology, St. Paul's Hospital, 161 Ethnikis Andistaseos Str, 551 34 Thessaloniki, Greece. sakelgr@otenet.gr
Vounotrypidis
Periklis
P
Berberidis
Charalampos
C
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D015535:Arthritis, Psoriatic / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D005922:Glomerulonephritis, IGA / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D000069285:Infliximab; D008297:Male; D008875:Middle Aged; D011507:Proteinuria / Q000188:drug therapy / Q000209:etiology / Q000473:pathology; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D000069285:Infliximab